Physician profile
Daniel J Holtz
NPI 1962680991
$6,175.40
in general payments reported to CMS, 2019-2025
14 companies · $46.28 in 2025
The $46.28 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,907 · 2020: $125 · 2021: $1,408 · 2022: $196 · 2023: $295 · 2024: $1,198 · 2025: $46.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $937 · Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $937.49 |
| Food and Beverage | $601.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $2,600.00 | 2019-2021 | |
| Axogen | $1,698.94 | 2019-2023 | Avance Nerve Graft |
| Arthrex, INC. | $615.30 | 2024 | |
| United Orthopedics LLC | $460.19 | 2024 | |
| Depuy Synthes Sales INC. | $249.70 | 2020-2021 | |
| Access Pro Medical, LLC | $168.44 | 2023 | Matriderm |
| Endo Pharmaceuticals INC. | $138.40 | 2023-2024 | Xiaflex |
| Acera Surgical, INC. | $68.19 | 2019 | |
| Endo USA, INC. | $46.28 | 2025 | Xiaflex |
| Cumberland Pharmaceuticals, INC. | $37.55 | 2022 | |
| Smith+Nephew, INC. | $37.11 | 2021 | |
| Ermi LLC | $20.05 | 2023 | |
| Arthrosurface Incorporated | $19.80 | 2019 | |
| Integra Lifesciences Corporation | $15.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Holtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.